JAGX: Jaguar Health, Inc. Stock

by  •  • Comments Off on JAGX: Jaguar Health, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 87.39
Enterprise Value ($M) 116.72
Book Value ($M) 4.90
Book Value / Share 0.02
Price / Book 17.85
NCAV ($M) -17.90
NCAV / Share -0.06
Price / NCAV -4.88

Profitability (mra)
Return on Invested Capital (ROIC) -0.98
Return on Assets (ROA) -0.73
Return on Equity (ROE) -5.39

Liquidity (mrq)
Quick Ratio 1.34
Current Ratio 2.00

Balance Sheet (mrq) ($M)
Current Assets 27.96
Assets 50.76
Liabilities 45.87
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 9.76
Operating Income -33.92
Net Income -41.30
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -33.24
Cash from Investing 0.00
Cash from Financing 34.23

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
12-29 13G Iliad Research & Trading, L.P. 9.60
07-13 13G Fife John M. 9.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-04-17 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1)
2024-04-01 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-K
2023-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-03 40,949,650 112,314,156 36.46
2024-05-02 52,920,044 9,453,722 559.78
2024-05-01 11,642,630 1,971,295 590.61
2024-04-30 32,557,040 5,356,716 607.78

(click for more detail)

Similar Companies
INMB – INmune Bio, Inc. INTS – Intensity Therapeutics, Inc.
ITRM – Iterum Therapeutics plc JAN – JanOne Inc.
JSPR – Jasper Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io